News

Search keyword

Export from Switzerland

Invest in Switzerland

About S-GE

EPFL’s innovation is designed to significantly enhance clinical decision-making by providing access to specialized medical knowledge.

EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.

Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical challenges such as heart valve diseases, grave skin defects, and erectile dysfunction.

Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical...

One of the future company divisions will offer products and systems for the cleaning, disinfection and sterilization of medical and surgical instruments in hospitals. Generic image: Kreuz_und_Quer/Pixabay

Metall Zug and Miele are establishing a joint venture. Metall Zug will integrate its business units specializing in the disinfection and steriliz...

In laboratory experiments, G.V. Shivashankar and his team were able to significantly speed up the regeneration and wound healing of skin tissue using stem-cell-like fibroblasts. Image credit: Paul Scherrer Institute/Markus Fischer

A group of researchers at the Paul Scherrer Institute have mechanically reprogrammed connective tissue cells to make a type of stem cells. This a...

T3 has developed a therapeutic platform that uses live bacteria to deliver immunomodulatory proteins into cancer cells and tumor microenvironments.

Boehringer Ingelheim has acquired T3 Pharma, which is based in the Switzerland Innovation Park Basel Area, for an amount of up to 450 million Swi...

This funding is a significant leap forward, enabling the company to expand its groundbreaking solutions into the US market while bolstering its presence in Europe.

Lausanne-based start-up biped.ai, known for its revolutionary technology aiding the visually impaired, has successfully raised CHF 1.2 million.

Empa researcher Federica Orellana works with a micro-computed tomography to analyze tissue samples of meniscus. Image credit: Empa

Biophysicists from the Swiss Federal Laboratories for Materials Science and Technology (Empa) are working on the development of customized therap...

CRISPR Therapeutics and Vertex have secured the world’s first regulatory authorization for a therapy approach based on the CRISPR gene scissors for genome editing.

The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...

Roche plans to invest a further 1.2 billion Swiss francs in renewing the infrastructure at its main site in Basel. Image credit: Roche

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment will be used to finance...

Geistlich Pharma launches a digital education program.

Geistlich Pharma is launching the Geistlich myGuide education program with a focus on dentistry and regenerative dentistry. The scientific partne...

The inclusion of Aktiia’s technology in the GAPP study is a testament to its potential in reshaping blood pressure research.

Neuchâtel start-up Aktiia, a pioneer in cuffless blood pressure monitoring, has embarked on a groundbreaking study in collaboration with eminent ...

Nouscom intends to use the funds to advance the clinical development of neoantigen cancer vaccines.

Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based company intends to use the funds to advance the clinical dev...

Empa is one of the partners who established the new “Dynamic Imaging Center” (DIC) in Bern.

sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.

From left to right: Christoph Ammann, Canton of Bern – Dr. med. h.c. Uwe E. Jocham, Insel Gruppe – Prof. Dr. Christian Leumann, University of Bern – Dr. Alexandre Pauchard, CSEM, Jens Krauss, CSEM.

The canton of Bern is on a mission to become a leading global medical hub by 2030. By combining an exceptional medical expertise medical expertis...

The BOOM Summit in April 2024 will be dedicated to trends in digital health technologies.

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference, say its organizers. The first edition will b...

Empa researcher Qun Ren is looking for new ways to combat persistent biofilms. Image credit: Empa

Researchers from Switzerland and the USA have jointly developed a dressing that uses probiotics to eliminate pathogens in chronic wounds. The pro...

LAGOSTA specializes in the sustainable farming of the European spiny lobster, converting byproducts in unique highly valuable products and setting up a series of ecological programs.

Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...

Onena intends to put the investment towards its efforts to provide in vivo proof of concept with its most advanced DSIP program (OMED-2).

Onena Medicines has secured investment of 3.7 million Swiss francs. The portfolio company of the biotech start-up incubator BaseLaunch will there...

Official program

Export
Invest

Daniel Bangser

Daniel Bangser

Investment Promotion Switzerland